Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Quest Diagnostics Inc (DGX) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 12,125,450
  • Shares Outstanding, K 138,640
  • Annual Sales, $ 7,493 M
  • Annual Income, $ 709 M
  • 36-Month Beta 0.65
  • Price/Sales 1.62
  • Price/Book 2.58

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.28 +11.00%
on 11/09/16
89.16 -1.30%
on 11/30/16
+7.02 (+8.67%)
since 11/02/16
3-Month
79.12 +11.22%
on 10/28/16
89.16 -1.30%
on 11/30/16
+4.96 (+5.97%)
since 09/02/16
52-Week
59.66 +47.50%
on 02/09/16
89.16 -1.30%
on 11/30/16
+19.31 (+28.11%)
since 12/02/15

Most Recent Stories

More News
Signal Bay Has the Experience Needed to Capture California's Massive Cannabis Testing Market

Many Cannabis Testing Companies Fail to Achieve Accreditation. Many Others Simply Fail.

Quest Diagnostics' QuestDirect Now in Colorado & Missouri

Quest Diagnostics Inc. (DGX) recently announced the launch of QuestDirect, a new Patient-Initiated Testing service in Colorado and Missouri.

Quest Diagnostics at 52-Week High on Solid Q3 & Prospects

Share price of Quest Diagnostics, Inc. (DGX) reached a new 52-week high of $87.48 on Nov 21, finally closing a bit lower at $87.29.

Quest Diagnostics to Expand Consumer Offering Through Patient-Initiated Testing Services in Colorado and Missouri

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has launched QuestDirect, a new Patient-Initiated Testing service which will empower consumers who live in...

Technical Reports on Healthcare Equities -- Organovo, Quest Diagnostics, Alere, and DexCom

Companies in the Medical Laboratories and Research industry are focused on performing various tests on patients that give them information on patients' health. As a whole, these firms tend to offer higher...

Upgrade Alert for Quest Diagnostics (DGX)

Quest Diagnostics (NYSE:DGX) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $85.09 on volume of 3.1 million shares, above average daily volume of 906,000. Over the past...

Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day

At a meeting with analysts and investors at its Investor Day today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information...

California Election Results Deliver Signal Bay $300 Million Cannabis Market

Historic Election Result Makes Recreational Marijuana Legal in California.

Griffin-American Healthcare REIT IV Enters Agreement to Acquire Evendale Medical Office Building Near Cincinnati

American Healthcare Investors and Griffin Capital Corporation, the co-sponsors of Griffin-American Healthcare REIT IV, Inc., announced today that the REIT has entered into an agreement to acquire Evendale...

Signal Bay's Target Market in California To Triple Overnight

Game Changing Election Result Will Make Recreational Marijuana Legal in California.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Support & Resistance

2nd Resistance Point 89.55
1st Resistance Point 88.77
Last Price 88.00
1st Support Level 87.28
2nd Support Level 86.57

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.